CVS Corp
(CVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,683,000 | 4,059,000 | 1,696,000 | 3,371,000 | 2,459,000 |
| Marketable Securities | 2,373,000 | 2,522,000 | 111,000 | 87,000 | 88,000 |
| Receivables | 19,617,000 | 17,631,000 | 13,181,000 | 12,164,000 | 11,888,000 |
| Inventories | 17,516,000 | 16,450,000 | 15,296,000 | 14,760,000 | 14,001,000 |
| Other current assets | 5,113,000 | 4,581,000 | 945,000 | 660,000 | 722,000 |
| TOTAL | $50,302,000 | $45,243,000 | $31,229,000 | $31,042,000 | $29,158,000 |
| Non-Current Assets | |||||
| PPE Net | 12,044,000 | 11,349,000 | 10,292,000 | 10,175,000 | 9,855,000 |
| Investments And Advances | 17,314,000 | 15,732,000 | 112,000 | 0 | 0 |
| Intangibles | 112,870,000 | 115,202,000 | 52,081,000 | 51,760,000 | 51,984,000 |
| Other Non-Current Assets | 29,919,000 | 8,930,000 | 1,417,000 | 1,485,000 | 1,440,000 |
| TOTAL | $172,147,000 | $151,213,000 | $63,902,000 | $63,420,000 | $63,279,000 |
| Total Assets | $222,449,000 | $196,456,000 | $95,131,000 | $94,462,000 | $92,437,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,781,000 | 1,985,000 | 4,821,000 | 1,916,000 | 1,197,000 |
| Accounts payable and accrued liabilities | 30,972,000 | 26,437,000 | 19,223,000 | 17,397,000 | 15,143,000 |
| Accrued Expenses | 12,133,000 | 10,711,000 | 6,581,000 | 6,937,000 | 6,829,000 |
| Other current liabilities | 4,821,000 | 4,876,000 | 23,000 | N/A | N/A |
| TOTAL | $53,303,000 | $44,009,000 | $30,648,000 | $26,250,000 | $23,169,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 64,699,000 | 71,444,000 | 22,181,000 | 25,615,000 | 26,267,000 |
| Other Non-Current Liabilities | 32,986,000 | 14,785,000 | 1,610,000 | 1,547,000 | 1,579,000 |
| TOTAL | $104,976,000 | $93,904,000 | $26,788,000 | $31,378,000 | $32,065,000 |
| Total Liabilities | $158,279,000 | $137,913,000 | $57,436,000 | $57,628,000 | $55,234,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,304,160 | 1,297,082 | 1,014,532 | 1,025,700 | 1,098,491 |
| Common Shares | 45,972,000 | 45,440,000 | 32,096,000 | 17,000 | 17,000 |
| Retained earnings | 45,108,000 | 40,911,000 | 43,556,000 | 38,983,000 | 35,506,000 |
| Other shareholders' equity | 1,325,000 | 420,000 | -161,000 | -332,000 | -382,000 |
| TOTAL | $64,170,000 | $58,543,000 | $37,695,000 | $36,834,000 | $37,203,000 |
| Total Liabilities And Equity | $222,449,000 | $196,456,000 | $95,131,000 | $94,462,000 | $92,437,000 |